Cases without B cells in subcortical WM showed a trend for a lower number of T cells in subcortical MS lesions (median 3.3 vs 8.3 cells/mm 2 ; p = 0.06; figure 3C ) and a lower overall percentage of mixed active/inactive lesions (mean 23.7% vs 39.6%; p = 0.01; figure 3D ) compared with MS donors with B cells.
Although insulin levels showed a trend toward reduction, the difference was not statistically significant ( p = 0.06).
Hypertensive AF patients (60/134) showed a trend towards a larger atrial CT-EAT-volume than non-hypertensive patients, 17.0 ± 7.6 versus 14.6 ± 6.7 ml/m 2 ( p = 0.06), and towards lower atrial CT-EAT-attenuation − 74.2 ± 5.3 versus − 72.8 ± 4.4HU, ( p = 0.10), respectively.
Intact proviruses showed a trend toward higher levels in the CD4 count ≥350 vs. <350 group (median 35 vs. 3 copies/10 6 cells, respectively, p = 0.06), while total proviruses were similar (median 1102 vs. 1047 copies/10 6 cells, respectively, p = 0.7) ( Figure 1 ).
For the primary safety outcome of major bleeding, the high-dose DOAC regimens showed a trend toward lower bleeding (RR 0.86, 95 % CI 0.73–1.00, p = 0.06).
Non-ventilated ALS patients with a frontotemporal syndrome showed a trend to a shorter survival compared to classic ALS patients without NIV (median 4.00 years, 95 % CI 3.43–3.82 vs. 3.59 years 95 % CI 2.55–4.62, p = 0.06).
There were no significant differences in seropositivity among males versus females; RR 1.08 (95% CI 0.58–2.01), P = 0.82, while having a link with schools (teachers or students) showed a trend to be associated with seropositivity RR 1.85 (95% CI 0.96–3.57), P = 0.06.
However, FAS and SREBP1c showed a trend ( p = 0.06) to be upregulated in TF from Chilota in contrast to Suffolk Down lambs. 3.2.
Statistical treatments showed a trend effect of tracking duration on home ranges area (Spearman's r = 0.52, n = 14, P = 0.06) and a lack of significant influence beyond 12 days of monitoring (Spearman's r = 0.38, n = 12, p = 0.23).
CKD stage distribution also showed a trend toward more advanced stages among patients who progressed ( p = 0.06).
As for bacterial eradication, the meta-analyses showed a trend to increased microbiological clearance (RR 1.93, p=0.06), although it did not achieve statistical significance.
Moreover, H 2 O 2 generation in DTCs showed a trend toward a correlation with extrathyroidal extension ( p = 0.06) ( Figure 3 ). 3.4.
Pacemaker implantation showed a trend toward higher rates with Calafiore (11.5%) compared to other groups (4.2–6.8%, p = 0.06).
Among those at low risk of PAWP elevation, exercise PVP indexed to peak V o 2 showed a trend for predicting exercise PVRI (β=0.32 WU·m 2 per mm Hg/100 mL per min [95% CI, 0.00–0.64]; P =0.06), whereas it was not in those at high risk (β=−0.43 WU·m 2 per mm Hg/100 mL per min [95% CI, −1.03 to 1.67]; P =0.13). ΔPVP with exercise indexed to peak V o 2 was also associated with ΔPVRI (β=0.91
Higher pre-FLOT SMI (HR: 0.95, p = 0.09) and tumors in the GEJ ( versus stomach, HR: 0.34, p = 0.07) showed a trend towards superior PFS whereas pre-FLOT sarcopenia ( versus no sarcopenia, HR: 2.83, p = 0.06; Fig. 1 b) showed a trend towards inferior PFS.
In this line, TnnC mRNA showed a trend towards lower levels in the EF group in comparison to both C1 ( p = 0.06) and AF ( p = 0.05)-fed fish.
The response rate was 16% in men and 13% in women ( p = 0.80), however, men showed a trend toward a larger response size relative to women ( F = 3.60, p = 0.060).
Polymicrobial infection showed a trend towards higher mortality (aOR 2.47, 95% CI 0.94–6.89; p = 0.06), although this association did not reach conventional statistical significance.
Baseline visual acuity was similar between groups (0.6 ± 0.6 vs 0.6 ± 0.6 logMAR, P = 0.92), while central macular thickness showed a trend toward difference (368.7 ± 172.0 vs 398.0 ± 169.4 μm, P = 0.06) (Table 1 ).
One-year follow-up Fibroid recurrence rates showed a trend toward lower rates in the 3D model group compared to the control group (1/55 [1.8%] vs. 7/55 [12.7%]; P = 0.060), approaching but not reaching statistical significance.
Cellular deconvolution analysis showed a trend toward an increase in smooth muscle cells in the EAT of patients with AF, albeit not significant ( P = 0.06) (Extended Data Fig. 3f,g ).
Canopy cover did not significantly correlate with the NMDS ordination but showed a trend toward decay class 2 ( r 2 = 0.06, p = 0.06).
They also showed a trend ( P = 0.06) for the high protein diet to enhance 5 km time trial performance compared to the low protein diet.
Post hoc exploratory analysis in the subset of participants with a length of stay less than 10 days (N = 20) showed a trend toward reduced length of stay with tolvaptan (5.0 days [IQR 4.3-5.8] vs 6.5 days [IQR 5.3-7.0]; P = .06).
Furthermore, this trial showed a trend of a lower incidence of urinary tract infections ( p = 0.06).